NURS 6630N-8 WEEK 11 FINAL EXAM

NURS 6630N-8 WEEK 11 FINAL EXAM
Review Test Submission:
Week 11 Final Exam
User
Course NURS-6630C-8/NURS-6630N-8-Approaches to Treatment2020
Spring Qtr 02/24-05/17-PT27
Test Week 11 Final Exam
Started 5/6/20 5:30 AM
Submitted 5/6/20 7:30 AM
Due Date 5/11/20 1:59 AM
Status Completed
Attempt 74 out of 75 points
Score
Time Elapsed 2 hours, 0 minute out of 2 hours
Results Submitted Answers
Displayed
 Question 1
1 out of 1 points


Brandon is a non-compliant patient that presents to the clinic asking for help with his
alcohol dependence. The PMHNP evaluates the patient and determines a long-acting
injection that blocks the mu-receptors would be the best treatment option for Brandon.
Which medication should the PMHNP prescribe?


Selected c.
Answer: Naltrexone
(VIVITROL)

 Question 2
1 out of 1 points


Sandra complains of constipation after being on quetiapine (SEROQUEL) for several
weeks. Constipation is likely caused by the binding of quetiapine (SEROQUEL) to which
receptor?


Selected b.
Answer: D
1

 Question 3
1 out of 1 points

, Even though both of these medications are useful in the treatment of ADHD, their actions
are different. Atomoxetine is a selective ______________________ reuptake inhibitor, while
bupropion is a selective __________________ reuptake inhibitor.


Selected d.
Answer: Norepinephrine / norepinephrine-
dopamine

 Question 4
1 out of 1 points


An adult patient presents with a history of alcohol addiction and attention deficit
hyperactivity disorder (ADHD). Given these comorbidities, the PMHNP determines which
of the following medications may be the best treatment option?


Selected d.
Answer: Atomoxetine
(Strattera)

 Question 5
1 out of 1 points


The PMHNP is attempting to treat a patient’s chronic insomnia and wishes to start with
an initial prescription that has a half-life of approximately 1–2 hours. What is the most
appropriate prescription for the PMHNP to make?


Selected b.
Answer: Triazolam
(Halcion)

 Question 6
1 out of 1 points


A patient with chronic insomnia and depression is taking trazodone (Oleptro) but
complains of feeling drowsy during the day. What can the PMHNP do to reduce the drug’s
daytime sedating effects?


Selected d.
Answer: Give the medicine at night and lower
the dose

 Question 7
1 out of 1 points


A young patient is prescribed Vyvanse. During the follow-up appointment, which
comment made by the patient makes the PMHNP think that the dosing is being done

, incorrectly?


Selected b.
Answer: “I am unable to fall asleep at
night.”

 Question 8
1 out of 1 points


Alcohol enhances inhibition at ____________ synapses and reduces excitation at
______________ synapses.


Selected c.
Answer: Dopeminergic /
Glugamate

 Question 9
1 out of 1 points


A patient’s daughter calls your office with concerns that her mother is having significant
gastrointestinal side effects. You review the patient’s chart and realize she is having side
effects from donepezil (ARICEPT). What is the mechanism of the gastrointestinal
disturbances?


Selected b.
Answer: Donepezil increases the activity of acetylcholinesterase in the peripheral
acetylcholine neurons and the decline in acetylcholine causes increased
side effects.

 Question 10
1 out of 1 points


Which of the following anticonvulsants increases serotonergic neurotransmission and
GABAergic transmission, while decreasing glutamatergic neurotransmission?


Selected a.
Answer: Topiramate
(TOPAMAX)

 Question 11
1 out of 1 points


A 75-year-old male patient diagnosed with Alzheimer’s disease presents with agitation
and aggressive behavior. The PMHNP determines which of the following to be the best
treatment option?